Peter Masci
Impact in
-
- Pancreatic and Hepatic Oncology Research
- Peptidase Inhibition and Analysis
- Viral-associated cancers and disorders
- Surgery top 10%
- Cholangiocarcinoma and Gallbladder Cancer Studies
- Pediatric Hepatobiliary Diseases and Treatments
Papers in
- Surgery 4
- Cholangiocarcinoma and Gallbladder Cancer Studies 4
-
- Gallbladder and Bile Duct Disorders 3
- Co-authors
- Daniel H. Ahn (4 shared papers)Mitesh J. Borad (4 shared papers)Tanios Bekaii‐Saab (4 shared papers)Rachna T. Shroff (3 shared papers)Robert A. Wolff (3 shared papers)Lianchun Xiao (3 shared papers)Milind Javle (3 shared papers)Michiko Iwasaki (3 shared papers)
- Journals
- Journal of Clinical Oncology (2 papers)Investigational New Drugs (1 paper)JAMA Oncology (1 paper)
- Partner nations
- United StatesBrazil
In The Last Decade
Peter Masci
4 papers receiving 357 citations
Peter Masci's Hit Papers
Peers
Comparison fields: 5 of 39
- Oncology 232
- Surgery 305
- Pulmonary and Respiratory Medicine 162
- Cancer Research 40
- Pathology and Forensic Medicine 41
Countries citing papers authored by Peter Masci
This map shows the geographic impact of Peter Masci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Masci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Masci more than expected).
Fields of papers citing papers by Peter Masci
This network shows the impact of papers produced by Peter Masci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Masci. The network helps show where Peter Masci may publish in the future.
Co-authors
The 24 scholars most cited alongside Peter Masci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of Advanced Biliary Tract Cancers Hit paper breakdown → | 2019 | 321 |
| 2 | 2021 | 23 | |
| 3 | 2017 | 13 | |
| 4 | 2018 | 2 |
About Peter Masci
Peter Masci is a scholar working on Surgery, Pulmonary and Respiratory Medicine, Oncology, Pharmacy and Molecular Biology, having authored 4 papers that have together received 359 indexed citations. Recurring topics across this work include Cholangiocarcinoma and Gallbladder Cancer Studies (4 papers), Gallbladder and Bile Duct Disorders (3 papers), Pancreatic and Hepatic Oncology Research (2 papers), Oral and gingival health research (2 papers) and Fibroblast Growth Factor Research (1 paper). The work is most often cited by research in Oncology (232 citations), Surgery (305 citations), Pulmonary and Respiratory Medicine (162 citations), Cancer Research (40 citations) and Pathology and Forensic Medicine (41 citations). Peter Masci has collaborated with scholars based in United States and Brazil. Frequent co-authors include Daniel H. Ahn, Mitesh J. Borad, Tanios Bekaii‐Saab, Rachna T. Shroff, Robert A. Wolff, Lianchun Xiao, Milind Javle, Michiko Iwasaki, Ahmed O. Kaseb and Gauri R. Varadhachary. Their work appears in journals such as Journal of Clinical Oncology, Investigational New Drugs and JAMA Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.